Jonathan D Zurawski, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Sclerosis | 16 | 2024 | 3204 | 2.050 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 6 | 2024 | 556 | 1.400 |
Why?
|
Meninges | 2 | 2019 | 197 | 1.090 |
Why?
|
Meningitis | 1 | 2017 | 218 | 0.490 |
Why?
|
Tolosa-Hunt Syndrome | 1 | 2013 | 2 | 0.460 |
Why?
|
Immunologic Factors | 3 | 2020 | 1588 | 0.450 |
Why?
|
Drug Substitution | 1 | 2016 | 296 | 0.440 |
Why?
|
Ophthalmoplegia | 1 | 2013 | 168 | 0.400 |
Why?
|
Magnetic Resonance Imaging | 10 | 2024 | 36290 | 0.370 |
Why?
|
Disability Evaluation | 5 | 2024 | 1826 | 0.340 |
Why?
|
Atrophy | 3 | 2024 | 1627 | 0.320 |
Why?
|
Rare Diseases | 1 | 2013 | 619 | 0.300 |
Why?
|
Cognition Disorders | 1 | 2020 | 3976 | 0.260 |
Why?
|
Headache | 1 | 2013 | 1249 | 0.250 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15840 | 0.230 |
Why?
|
Quality of Life | 4 | 2021 | 13308 | 0.230 |
Why?
|
Disease Progression | 2 | 2021 | 13502 | 0.210 |
Why?
|
Familial Mediterranean Fever | 1 | 2023 | 65 | 0.210 |
Why?
|
Brain | 7 | 2024 | 26951 | 0.190 |
Why?
|
Demyelinating Diseases | 1 | 2023 | 351 | 0.180 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 1 | 2021 | 254 | 0.160 |
Why?
|
Interferon-beta | 1 | 2018 | 345 | 0.140 |
Why?
|
Middle Aged | 14 | 2024 | 220352 | 0.140 |
Why?
|
Computers | 1 | 2018 | 595 | 0.130 |
Why?
|
Adult | 14 | 2024 | 219994 | 0.130 |
Why?
|
Risk Assessment | 1 | 2016 | 24123 | 0.120 |
Why?
|
Longitudinal Studies | 3 | 2019 | 14495 | 0.120 |
Why?
|
Meningitis, Aseptic | 1 | 2014 | 59 | 0.110 |
Why?
|
Cytoskeletal Proteins | 2 | 2010 | 1343 | 0.110 |
Why?
|
Vaccines | 1 | 2022 | 832 | 0.110 |
Why?
|
Social Stigma | 1 | 2020 | 734 | 0.110 |
Why?
|
Female | 17 | 2024 | 391270 | 0.110 |
Why?
|
Cavernous Sinus | 1 | 2013 | 123 | 0.100 |
Why?
|
Computational Biology | 1 | 2024 | 3505 | 0.100 |
Why?
|
Humans | 24 | 2024 | 760621 | 0.100 |
Why?
|
Vasoconstriction | 1 | 2014 | 593 | 0.090 |
Why?
|
Male | 12 | 2024 | 359744 | 0.090 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2024 | 8950 | 0.090 |
Why?
|
Recurrence | 3 | 2022 | 8482 | 0.090 |
Why?
|
Intracellular Fluid | 1 | 2010 | 201 | 0.090 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2852 | 0.090 |
Why?
|
Diagnosis, Differential | 2 | 2017 | 12965 | 0.090 |
Why?
|
Growth Cones | 1 | 2010 | 117 | 0.090 |
Why?
|
Myelin Proteins | 1 | 2010 | 208 | 0.090 |
Why?
|
Neural Inhibition | 2 | 2010 | 589 | 0.080 |
Why?
|
Posterior Horn Cells | 1 | 2010 | 90 | 0.080 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2010 | 2895 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4550 | 0.080 |
Why?
|
Prednisone | 1 | 2013 | 1565 | 0.080 |
Why?
|
Glucocorticoids | 1 | 2017 | 2145 | 0.080 |
Why?
|
Retrospective Studies | 5 | 2024 | 80372 | 0.070 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2019 | 3340 | 0.070 |
Why?
|
Pruritus | 1 | 2010 | 377 | 0.070 |
Why?
|
Vision Disorders | 1 | 2013 | 1084 | 0.070 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9185 | 0.060 |
Why?
|
Administration, Oral | 1 | 2013 | 4035 | 0.060 |
Why?
|
Drug Administration Schedule | 1 | 2013 | 4899 | 0.060 |
Why?
|
Interneurons | 1 | 2010 | 591 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4166 | 0.060 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 1139 | 0.060 |
Why?
|
Anti-Inflammatory Agents | 1 | 2013 | 1796 | 0.060 |
Why?
|
Algorithms | 1 | 2024 | 13981 | 0.060 |
Why?
|
Cerebrovascular Circulation | 1 | 2014 | 2733 | 0.060 |
Why?
|
Databases, Factual | 1 | 2019 | 8035 | 0.050 |
Why?
|
Glia Maturation Factor | 1 | 2022 | 13 | 0.050 |
Why?
|
Muromonab-CD3 | 1 | 2022 | 104 | 0.050 |
Why?
|
Cognition | 1 | 2020 | 6957 | 0.050 |
Why?
|
Phenotype | 1 | 2020 | 16546 | 0.050 |
Why?
|
Colchicine | 1 | 2023 | 261 | 0.050 |
Why?
|
Antigens, CD20 | 1 | 2022 | 201 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2013 | 10827 | 0.050 |
Why?
|
Administration, Intranasal | 1 | 2022 | 471 | 0.050 |
Why?
|
Research Subjects | 1 | 2022 | 249 | 0.040 |
Why?
|
Axons | 1 | 2008 | 1673 | 0.040 |
Why?
|
Time Factors | 2 | 2019 | 40165 | 0.040 |
Why?
|
Risk Factors | 2 | 2017 | 74359 | 0.040 |
Why?
|
Prognosis | 1 | 2017 | 29658 | 0.030 |
Why?
|
Cohort Studies | 1 | 2019 | 41335 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 17790 | 0.030 |
Why?
|
Fatigue | 1 | 2021 | 1544 | 0.030 |
Why?
|
Microfilament Proteins | 2 | 2010 | 1135 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2380 | 0.030 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3143 | 0.020 |
Why?
|
Mice, Neurologic Mutants | 1 | 2010 | 107 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3361 | 0.020 |
Why?
|
Subcellular Fractions | 1 | 2010 | 532 | 0.020 |
Why?
|
Growth Inhibitors | 1 | 2010 | 378 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8555 | 0.020 |
Why?
|
Neurons | 1 | 2008 | 9426 | 0.020 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2010 | 256 | 0.020 |
Why?
|
Stem Cells | 1 | 2022 | 3523 | 0.020 |
Why?
|
Nonmuscle Myosin Type IIA | 1 | 2008 | 28 | 0.020 |
Why?
|
Gene Knock-In Techniques | 1 | 2010 | 419 | 0.020 |
Why?
|
Genomics | 1 | 2024 | 5794 | 0.020 |
Why?
|
Genetic Complementation Test | 1 | 2008 | 555 | 0.020 |
Why?
|
Two-Hybrid System Techniques | 1 | 2008 | 458 | 0.020 |
Why?
|
Signal Transduction | 1 | 2010 | 23376 | 0.020 |
Why?
|
rho-Associated Kinases | 1 | 2008 | 281 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2010 | 2672 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 2010 | 1411 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2010 | 18957 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2008 | 1697 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2022 | 65017 | 0.010 |
Why?
|
Neuronal Plasticity | 1 | 2010 | 1430 | 0.010 |
Why?
|
Spinal Cord | 1 | 2010 | 1817 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2008 | 3800 | 0.010 |
Why?
|
Cell Survival | 1 | 2010 | 5797 | 0.010 |
Why?
|
RNA Interference | 1 | 2008 | 2846 | 0.010 |
Why?
|
Mice | 3 | 2010 | 81208 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2010 | 14372 | 0.010 |
Why?
|
Rats | 1 | 2010 | 23711 | 0.010 |
Why?
|
Child | 1 | 2022 | 79806 | 0.010 |
Why?
|
Animals | 3 | 2010 | 167963 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2008 | 5761 | 0.010 |
Why?
|
Aged | 1 | 2022 | 169152 | 0.010 |
Why?
|
Young Adult | 1 | 2014 | 58741 | 0.000 |
Why?
|